(2018). Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: Current evidence and safety profile of erenumab [Corrigendum]. J Pain Res.
Citação norma Chicago"Calcitonin Gene-related Peptide Receptor As a Novel Target for the Management of People With Episodic Migraine: Current Evidence and Safety Profile of Erenumab [Corrigendum]." J Pain Res 2018.
Citação norma MLA"Calcitonin Gene-related Peptide Receptor As a Novel Target for the Management of People With Episodic Migraine: Current Evidence and Safety Profile of Erenumab [Corrigendum]." J Pain Res 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.